Protamine News and Research

RSS
New clinical practice guideline provides recommendations for use of anticoagulants during heart surgery

New clinical practice guideline provides recommendations for use of anticoagulants during heart surgery

Protamine may be useful in developing new types of disinfectant solutions for contact lenses

Protamine may be useful in developing new types of disinfectant solutions for contact lenses

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Northwestern University researchers find safer way to improve surgery outcomes

Northwestern University researchers find safer way to improve surgery outcomes

Study offers insights into mechanisms of bacterial resistance to antimicrobial peptides

Study offers insights into mechanisms of bacterial resistance to antimicrobial peptides

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Adocia announces positive final results for first clinical trial of BioChaperone Combo

Adocia announces positive final results for first clinical trial of BioChaperone Combo

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Protamine antidote can be effective in reversing low-molecular-weight heparin

Protamine antidote can be effective in reversing low-molecular-weight heparin

Adocia reports positive preliminary results for first clinical trial of BioChaperone Combo

Adocia reports positive preliminary results for first clinical trial of BioChaperone Combo

Boehringer signs agreement with Brigham to conduct long-term study program on oral anticoagulants

Boehringer signs agreement with Brigham to conduct long-term study program on oral anticoagulants

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

Protamine–heparin complex antibodies raise concerns

Protamine–heparin complex antibodies raise concerns

Dabigatran decreases risk of recurrent venous thromboembolism

Dabigatran decreases risk of recurrent venous thromboembolism

FDA approves Cardiva Medical's VASCADE Vascular Closure System

FDA approves Cardiva Medical's VASCADE Vascular Closure System

Bristol-Myers Squibb, Pfizer receive FDA approval for ELIQUIS to reduce risk of stroke and SE

Bristol-Myers Squibb, Pfizer receive FDA approval for ELIQUIS to reduce risk of stroke and SE

Updated U.S. prescribing information for Boehringer Ingelheim’s Pradaxa

Updated U.S. prescribing information for Boehringer Ingelheim’s Pradaxa

Pradaxa use does not appear to increase serious bleeding

Pradaxa use does not appear to increase serious bleeding

PolyMedix Phase 1B/2 clinical study data presented at ATVB meeting

PolyMedix Phase 1B/2 clinical study data presented at ATVB meeting

New nano-systems capable of binding heparin as effectively as protamine

New nano-systems capable of binding heparin as effectively as protamine